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Self-renewal and proliferation of neural stem cells
and the decision to initiate neurogenesis are crucial
events directing brain development. Here we show
that the ubiquitin ligase Huwe1 operates upstream
of the N-Myc-DLL3-Notch pathway to control neural
stem cell activity and promote neurogenesis. Condi-
tional inactivation of the Huwe1 gene in the mouse
brain caused neonatal lethality associated with dis-
organization of the laminar patterning of the cortex.
These defects stemmed from severe impairment of
neurogenesis associated with uncontrolled expan-
sion of the neural stem cell compartment. Loss- and
gain-of-function experiments in the mouse cortex
demonstrated that Huwe1 restrains proliferation and
enables neuronal differentiation by suppressing the
N-Myc-DLL3 cascade. Notably, human high-grade
gliomas carry focal hemizygous deletions of the
X-linked Huwe1 gene in association with amplifica-
tion of the N-myc locus. Our results indicate that
Huwe1 balances proliferation and neurogenesis in
the developing brain and that this pathway is sub-
verted in malignant brain tumors.
INTRODUCTION
During development of mammalian neocortex, generation of
neurons (neurogenesis) is preceded by proliferation of neural
stem cells and committed progenitors in the germinal compart-
ments lining the cerebral ventricles—the ventricular zone (VZ)
and the subventricular zone (SVZ) (Doe, 2008; Gotz and Huttner,
2005). Neocortical neurogenesis in the VZ of the normal mouse210 Developmental Cell 17, 210–221, August 18, 2009 ª2009 Elseviextends from E11 through E18 (Takahashi et al., 1993, 1994,
1995a, 1995b). During this time the cell cycle length increases,
the proliferating fraction of neuroepithelial progenitors in the VZ
gradually decreases, and the fraction of cells exiting the cell
cycle and undergoing differentiation progressively increases
(Dehay and Kennedy, 2007; Gotz and Huttner, 2005; Takahashi
et al., 1995a, 1995b). The increasing fraction of progenitors with-
drawing from the cell cycle is paralleled by activation of differen-
tiation programs for the neuronal lineage, thus ensuring that the
correct number of neuronal subtypes are consistently generated
and form the functional circuits that orchestrate the laminar orga-
nization of the cortex (Kintner, 2002). Protein ubiquitination has
recently emerged as a rapid and efficient posttranslational modi-
fication of substrates that regulates many biological conditions.
Specificity for distinct substrates is conferred by the E3 ubiquitin
ligase subunit. When ubiquitin tagging to intracellular substrates
occurs through Lys48-linked polyubiquitin chains, proteins are
labeled for 26S proteasome-mediated recognition and proteo-
lytic destruction. Little is known about the nature and dynamics
of E3 ubiquitin ligases that, in response to antimitogenic and dif-
ferentiative signals, modify key transcriptional regulators to insti-
gate the transition from dividing neural progenitors to postmitotic
neurons.
Huwe1 encodes a HECT domain ubiquitin ligase. Through
covalent interactions with the catalytic cysteine residue, HECT
domain ligases accept ubiquitin from E2 ubiquitin-conjugating
enzymes and transfer the ubiquitin to specific substrates (Huang
et al., 1999). Huwe1 is a large protein (500 kD) that has
attracted considerable interest because several and quite dispa-
rate substrates have been assigned to this E3 (histones, Mcl1,
p53, c-Myc, cdc6, N-Myc) (Adhikary et al., 2005; Chen et al.,
2005; Hall et al., 2007; Liu et al., 2005; Zhao et al., 2008; Zhong
et al., 2005). Not surprisingly, the biological functions of Huwe1
remain controversial (Bernassola et al., 2008). We have gener-
ated mice in which the region coding for the HECT domain ofer Inc.
Developmental Cell
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the mouse brain disclosed that Huwe1-mediated ubiquitination
is essential to restrain proliferation, elicit neurogenesis, and
establish the laminar structure of the cortex. This activity is abol-
ished in malignant brain tumors containing genetic or epigenetic
inactivation of Huwe1.
RESULTS
Targeted Inactivation of Huwe1 in the CNS Results
in Neonatal Lethality
The pattern of expression of the Huwe1 protein in the nervous
system is characterized by an increasing gradient, with the
lowest amounts in the regions that contain neural stem cells/
undifferentiated progenitors (VZ/SVZ) and the highest levels in
differentiated neurons (cortical plate [CP]) (Zhao et al., 2008).
To determine the requirement for Huwe1 during development
of the nervous system, we used a conditional Huwe1 mutant
allele in which exon 80 and exon 82, which encode the HECT
domain of the Huwe1 protein, were flanked by LoxP sites (Zhao
et al., 2008). To inactivate Huwe1, we used a Cre deleter strain
that was driven by the Nestin promoter, resulting in expression
throughout the nervous systems from E10.5 (Lothian et al.,
1999). Huwe1 gene is X-linked, thus we performed our analysis
on male offspring because inactivation of the single Huwe1
allele in this gender results in the Huwe1 null genotype (see
Figure S1A available online). Crossings between Huwe1Flox/X or
Huwe1Flox/Flox females and Nestin-Cre transgenic males gener-
ated Huwe1Flox/YNestin-Cre animals (hereafter referred to as
Huwe1F/YNes). We observed efficient deletion of Huwe1 in the
nervous system (Figures S1A and S1B). Western blot and immu-
nofluorescence analysis of Huwe1 protein using two antibodies
recognizing the N terminus (Huwe1 N-ter) or the HECT domain
at the C terminus (Huwe1 HECT) confirmed that the HECT domain
was absent in the brain of Huwe1F/YNes pups. Moreover, the
mutant Huwe1 protein was markedly reduced, suggesting
that C-terminal deletion destabilized the residual polypeptide
(Figures S1C and S1D). Huwe1F/YNes mice were born with the
expected ratio. However, all Huwe1F/YNes neonates died within
24 hr of postnatal life (Table S1 available online).
Deletion of Huwe1 Deregulates Proliferation
and Impairs Cell Cycle Withdrawal and Lengthening
of Cell Cycle Timing of Cortical Progenitors
The brains from Huwe1F/YNes newborns were slightly smaller
than those from Huwe1F/Y or Huwe1+/YNes and wild-type litter-
mates. Histologic analysis of the mutant brains at E18.5 and
P0 revealed distinct abnormalities in various regions of the brain,
including cerebral cortex, hippocampus, and cerebellum (Fig-
ures S2A, S2E, and S2F). Mutant mice had a poorly developed
dentate gyrus and an immature, very small cerebellum (Figures
S2E and S2F). In Huwe1F/YNes mice cortical thickness was
significantly reduced, the laminar organization was altered, and
superficial neuron layers were not clearly identifiable (Fig-
ure S2C). Conversely, the germinal layers (VZ/SVZ) that contain
proliferating neural stem/progenitor cells were expanded and
extended into regions normally occupied by differentiating cells.
Despite the overall reduction in cortical size, cellular density
throughout the cortex was increased and intervening neuropilDevelodecreased (Figures S2A and S2C). Furthermore, mutant brains
contained ectopic cellular clusters in differentiated striatal
regions or, more rarely, other postmitotic areas of the brain
(Figures S2B and S2D). At E15.5 histology abnormalities were
barely discernible in mutant brains.
The increased cellular density in the neonatal cortex sug-
gested that neuronal production was abnormal. To study cell
proliferation, we performed quantitative analysis of the prolifera-
tion marker Ki67 at different embryonic stages (E13.5, E15.5, and
E18.5). At each stage of development Huwe1 knockout cortices
contained significantly higher numbers of proliferating cells
(Figures 1A, S3A, and S3B). Germinal areas (VZ and SVZ) were
primarily involved in the proliferative expansion. However, the
ectopic clusters dispersed throughout postmitotic and differen-
tiated regions of the Huwe1 knockout brain were also invariably
positive to Ki67 (Figure 1B). Therefore, loss of Huwe1 deregu-
lates the growth control in the nervous system and causes
expansion of the germinal layers and ectopic clustering of
proliferating cells. Also the higher number of Ki67-positive cells
in Huwe1F/YNes E13.5 and E15.5 embryos indicated that hyper-
proliferation precedes cortical abnormalities in Huwe1 null
brains.
Cortical neurogenesis is associated with progressive length-
ening of the cell cycle and results in increased fraction of progen-
itors that exit the cell cycle and differentiate (Dehay and Kennedy,
2007; Gotz and Huttner, 2005). We asked whether the expansion
of the neural progenitor pool in Huwe1F/YNes animals is conse-
quent to defective withdrawal and/or shortening of the cell cycle
in comparison with normal brains. We analyzed the probability to
withdraw from cycling and the cell cycle timing in Huwe1F/YNes
and wild-type embryos. First, we determined the fraction of cells
that exit cell cycle after 24 hr labeling with bromodeoxyuridine
(BrdU). The cell cycle exit was estimated as the fraction of
BrdU-positive cells that lost positivity for Ki67 (BrdU+/Ki67)
and the total number of BrdU-positive cells. Quantification of
these experiments from multiple pairs of Huwe1 null and control
brains at E13.5, E15.5, and E18.5 demonstrated that the fraction
of progenitors that exited cell cycle was significantly lower in
Huwe1 null brains at each developmental age (Figures 1C, S3C,
and S3D). To unravel potential changes in cell cycle timing, we
determined the proportion of cortical progenitors labeled by
1 hr pulse BrdU, whereby neural progenitor cells are identified
by Ki67 staining. Because the length of S phase remains constant
throughout development, a larger fraction of BrdU-positive
neural progenitors (Ki67-positive) would indicate shortening of
the cell cycle, whereas a lower proportion would imply a pro-
longed cell cycle timing. Quantification of results from three pairs
of control and Huwe1 null brains indicated that the length of the
cell cycle of the mutants was indistinguishable from that of the
wild-type brains at E13.5 and E15.5 (Figures S4A and S4B).
However, when the same analysis was conducted at E18.5,
Huwe1 null brains contained a significantly higher fraction of
BrdU-positive progenitors, thus indicating that loss of Huwe1
shortened cell cycle timing at the latest stages of neural develop-
ment (Figure 1D). Taken together, cell cycle withdrawal and
timing analyses suggest that the primary defect caused by loss
of Huwe1 is the reduced probability to exit from active cycling.
However, as development proceeds,Huwe1 inactivation impairs
also the lengthening of cell cycle timing, which is normallypmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevier Inc. 211
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Huwe1-N-Myc-DLL3 in Brain Development and CancerFigure 1. Deletion of the HECT Domain of Huwe1 in the Brain Increases the Size of the Progenitor Pool and Alters Cell Cycle
(A) Sagittal sections of the cortex of embryos at E18.5 were stained for Ki67 (upper panels) and counterstained with DAPI (lower panels). Quantification of Ki67+
cells normalized by area (150 mm2) is shown in the graph. Bars indicate mean ± SD; n = 3 for Huwe1F/Y and 3 for Huwe1F/YNes; p = 0.0008.
(B) Cortical sections at E18.5 were stained for Ki67 (red) and counterstained with DAPI (blue). Clusters of Ki67+ cells are detected in Huwe1F/YNes basal ganglia
(upper panel) and mesencephalic area (lower panel). Arrowheads indicate Ki67+ clusters of cells. IV, IV ventricle.
(C) Immunofluorescence for Ki67 (red) and BrdU (green) 24 hr after a single pulse of BrdU in E15.5 embryos. The fraction of cells labeled only with BrdU
(BrdU+/Ki67, no longer dividing), as compared with BrdU+/Ki67+ cells (re-entering cell cycle), was scored. Bars indicate mean ± SD; n = 3 for Huwe1F/Y and
3 for Huwe1F/YNes; p = 0.016.
(D) Immunofluorescence for Ki67 (red) and BrdU (green) after 1 hr pulse of BrdU in E18.5 embryos. The fraction of cycling progenitor cells (Ki67+) labeled with BrdU
was scored. Bars indicate mean ± SD; n = 3 for Huwe1F/Y and 3 for Huwe1F/YNes; p = 0.006. Arrows indicate BrdU+/Ki67+.associated with the increased rate of progenitors undergoing
differentiation during late neurogenesis.
Perturbation of Differentiation and Disruption
of Cortical Layering in the Huwe1 Null Brain
We determined whether the ability to differentiate was also per-
turbed in Huwe1 null brains. The RNA binding protein HuC/D is
an early marker of neuronal differentiation expressed in the
developing cortical plate since the initial stages of neurogenesis.
It functions to promote neuronal differentiation by modulating the
expression of genes required for axonal outgrowth such as the
gene encoding for the GAP43 protein (Ekstrom and Johansson,
2003). HuC/D and GAP43 were readily detected in wild-type
cortices at E15.5, but the expression of the two markers was
notably reduced in Huwe1F/YNes brains (Figure 2A). GAP43
was also diminished in the mutant cortex at E18.5 (Figure S5A).
The developmental progression from a neuroepithelial progen-
itor/radial glia phenotype, characteristic of the VZ, to an interme-
diate progenitor phenotype, predominant in the SVZ, is accom-
panied by downregulation of the homeodomain transcription
factor Pax6 and concomitant induction of the T-box transcription212 Developmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevfactor Tbr2 (Englund et al., 2005). We compared the size and spa-
tial distribution of these populations between the Huwe1F/YNes
and control brains at E18.5. In wild-type cortex Pax6 was
confined to the thin VZ layer and Tbr2 was detected as a more
superficial domain coinciding with the SVZ. Conversely, Huwe1
null cortex exhibited expansion and increased cellular density
of the Pax6 expressing domain with consequent superficial
displacement of the Tbr2-positive region. The thickness of the
Tbr2 domain was similar among wild-type and Huwe1 null
cortices (Figure 2B, see also Figure S5B for P0). These findings
indicate that loss of Huwe1 in the cortex induces uncontrolled
growth of the Pax6-expressing stem/progenitor population,
which remains negative for Tbr2. Next, we used molecular
markers to determine the consequences of genetic inactivation
of Huwe1 on laminar structure of the cortex. In the normal brain
the transcription factor Tbr1 and the Ctip2 protein are expressed
in the deep cortical layers and mark early-born neurons. As late-
born neurons populate the upper layers of the cortex, more
superficial layers positive for MAP2, Cux1, and p27Kip2 (layers
II–III) juxtapose the Tbr1/Ctip2-expressing domains. Staining
for Tbr1 and Ctip2 demonstrated decreased thickness butier Inc.
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deep layers in Huwe1F/YNes embryos and neonates (Figures
2C and S5C). Moreover, the most superficial layers of the cortical
plate of Huwe1 null embryos (layers II–III), marked by expression
of MAP2, Cux1, and p27Kip2, reached only a rudimentary devel-
opment, being mostly occupied by a disordered population of
Tbr1/Ctip2-positive neurons (Figures 2C, 2D, and S5C). To
examine the efficiency of neuronal production and explore the
mechanisms that lead to perturbed lamination in the Huwe1F/Y
Nes brain, we determined the position of neurons that became
postmitotic at different times using the BrdU ‘‘birthdating’’
method. To examine early neurogenesis (deep layer neurons),
BrdU was given to pregnant females when their embryos were
at E12.5. To examine late neurogenesis (superficial layers),
BrdU was given at E15.5; in both cases brains were dissected
at P0. BrdU labeling at E12.5 showed no major defect in the posi-
tion and absolute number of deep layer Tbr1-positive neurons
(Figure S6A and S6B). However, a differentiation defect was
already evident at this stage because mutant brains contained
a significantly lower fraction of BrdU-positive neurons that
stained positive for Tbr1 (Figure S6B, right panel). We interpret
Figure 2. Defective Cortical Differentiation,
Lamination, and Neurogenesis in
Huwe1F/YNes Embryos
(A) Sagittal sections of the cortex of embryos at
E15.5 stained for HuC/D (upper panel) and
GAP43 (lower panel). Arrows point to regions in
which GAP43 expression is reduced.
(B) Staining for Pax6 (green, upper panels) and
Tbr2 (red, lower panels) in E18.5 brains. Nuclei
were counterstained with DAPI (blue). Note the
expansion of the Pax6 domain with superficial
displacement of the Tbr2+ region in the Huwe1
null cortex.
(C) Immunofluorescence for MAP2 (green), Tbr1
(red) (upper panels), and Ctip2 (lower panels) in
E18.5 cortices. Nuclei were counterstained with
DAPI (blue).
(D) Staining for Cux1 (upper panels) and p27Kip1
(lower panels) in E18.5 cortices. Nuclei were coun-
terstained with DAPI (blue).
(E) Immunofluorescence for BrdU (red) and Tbr1
(green) on cortical sections of P0 pups after injec-
tion of BrdU at E15.5.
(F) Quantification of BrdU+ neurons in the superfi-
cial layers (II–III) marked by dashed lines in (E).
Bars indicate mean ± SD; n = 4 for Huwe1F/Y and
4 for Huwe1F/YNes; p = 0.0005.
these findings to indicate that, although
the percentage of progenitors under-
going differentiation is reduced in the
Huwe1 null cortex, the larger pool of pro-
genitors available in the knockout brain
accounts for a comparable number of
Tbr1-positive neurons in layer VI. BrdU
labeling at E15.5 indicated that the ability
to generate neurons that migrate to the
most superficial layers was markedly
reduced in the absence of Huwe1 (Fig-
ures 2E and 2F). The observation that the Huwe1 null brain
displays normal staining pattern for Reelin, a key regulator of
radial migration (Figure S6C), suggests that the increased neuron
packing density in the mutant cortex is not secondary to cell-
intrinsic migration defects. In sum, Huwe1 directs differentiation
in the developing mouse cortex and is essential for the neuronal
differentiation events that accompany the generation of late-
born neurons in layers II–III.
The Expression Level of Huwe1 Controls Activation
of a Neural-Specific N-Myc Regulon
To identify the mechanistic basis of the Huwe1 knockout pheno-
type, we asked whether loss of Huwe1 resulted in accumulation
of N-Myc and uncontrolled activation of molecular events down-
stream of N-Myc. Immunostaining of control and Huwe1 knock-
out brain revealed that N-Myc was elevated at E13.5, E15.5, and
E18.5 (Figure 3A, upper panels, and Figures S7A and S7B, upper
panels). D-type cyclins are established N-Myc target genes and
are expressed in the developing CNS (Glickstein et al., 2007;
Oliver et al., 2003). As for N-Myc, cyclin D1 was also weakly
expressed throughout the cortical layers of wild-type embryos,Developmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevier Inc. 213
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Huwe1-N-Myc-DLL3 in Brain Development and CancerFigure 3. Huwe1 Negatively Regulates the Accumulation and Activity of N-Myc
(A) E18.5 cortical sections were stained for N-Myc (upper panel) and cyclin D1 (lower panels). LV, lateral ventricle.
(B) The N-Myc subnetwork in GBM. Positively and negatively connected genes are shown in pink and green, respectively.
(C) Ranking of the top 30 transcription factors showing changes in their regulon expression based on the Huwe1 expression status in 236 human GBM. Positive
and negative normalized enrichment score (NES) values indicate positive and negative association (respectively) of the transcription factor’s activities with the
expression of Huwe1.
(D) GSEA2 plot for N-Myc regulon genes. All genes are sorted on the horizontal axis according to their differential expression between two extreme expression
states of Huwe1, with the most downregulated gene on the left and the most upregulated gene on the right. Red/blue bars indicate overlaps between the ranked
list and the individual positive/negative N-Myc targets (p < 1 3 105).but it was notably elevated in the absence of Huwe1 (Figure 3A,
lower panels, and Figure S7B, lower panels). Although elevation
of cyclin D1 (and downregulation of p27Kip2, Figure S7C) may
explain some of the events elicited by deregulated N-Myc in
the Huwe1 knockout cortex, Myc transcription factors display
remarkable cell-type specificity for target activation (Eilers and
Eisenman, 2008). To unravel the complement of N-Myc tran-
scriptional targets (regulon) in the nervous system, we devel-
oped a screen for N-Myc target genes based on a reverse
engineering approach. This analysis was performed on 176 ma-
lignant glioma samples that had been analyzed by global gene
expression profiling (Phillips et al., 2006; Freije et al, 2004; Nigro
et al., 2005), and the ARACNe algorithm (algorithm for the recon-
struction of accurate cellular networks) was used to infer a global214 Developmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevitranscriptional network (Basso et al., 2005). N-Myc, but not
c-Myc, emerged among the 10% largest transcriptional hubs,
displaying an inferred subnetwork of 230 highly significant
inferred targets (p < 0.005, Bonferroni corrected), among which
88 are positively regulated and 142 repressed by N-Myc
(Figure 3B and Table S2). Having identified a neural-specific
set of N-Myc-regulated target genes (the N-Myc regulon), we
interrogated the expression profile tumor data set—236 glioblas-
toma (GBM) samples—from The Cancer Genome Atlas (TCGA)
project to determine whether the N-Myc regulon is differentially
regulated in tumor sample subsets where Huwe1 is differentially
expressed (i.e., low expression in one subset and high expres-
sion in the other). The two subsets were generated by sorting
all glioma samples by Huwe1 expression and then by selectinger Inc.
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(A) Chromatin immunoprecipitation shows that the N-Myc protein binds the promoter of DLL3, but not OLR1, in neuroblastoma cells.
(B) Quantitative RT-PCR for DLL3 after ectopic expression of N-Myc in mouse embryo fibroblasts (MEFs). Values were normalized for b-actin. Bars indicate
mean ± SD of triplicate samples, p = 4.5 3 106.
(C) Western blot for cleaved Notch1, N-Myc, and b-actin.
(D) Correlation of the expression of N-myc and DLL3 in human GBM cells cultured in NBE (blue dots) and serum (red dots).
(E) RNA was prepared from E18.5 and P0 brains and analyzed by quantitative RT-PCR for the indicated genes. Values are normalized for b-actin. Bars indicate
mean ± SD; n = 6 for Huwe1FY and 6 for Huwe1F/YNes; p = 0.00027 for DLL3.
(F) Brain sections from E15.5 (upper panels) and E18.5 (lower panels) embryos were stained for cleaved Notch1.the first and last 83 (35%) samples. Differential regulation of the
N-Myc regulon was assessed using an extension of the Gene Set
Enrichment Analysis (GSEA) method (Subramanian et al., 2005),
called GSEA2, developed to simultaneously analyze the enrich-
ment of both activated and repressed targets of a transcription
factor (see Experimental Procedures and Lim et al., 2009).
When a Gene Ontology (GO) database-derived list of over
1000 transcription factors was tested for differential activity on
their regulon, conditional on Huwe1 expression, N-Myc was
ranked among the top 30 (Figure 3C). The analysis of the
GSEA2 plot revealed marked loss of N-Myc transcriptional
activity in tumors with high Huwe1 expression, i.e., concurrent
downregulation of N-Myc-activated targets and upregulation of
N-Myc-repressed targets (p < 1 3 105, Figure 3D). We also
asked whether Huwe1 controls the activity of c-Myc. The
GBM-derived regulon of c-Myc was noticeably smaller than
that of N-Myc (97 versus 230 inferred targets, Figure S8A and
Table S3). The GSEA2 plot showed that the c-Myc regulon was
similarly inactivated in tumors with high Huwe1 expression
(Figure S8B). Taken together, the computational results indicate
that Huwe1 operates as repressor of N-Myc and c-Myc tran-
scription in neural tissue.
Recruitment of Active Notch Signaling by N-Myc Protein
Accumulation in Huwe1 Knockout Brain
One of the highest-confidence N-Myc-positive targets inferred
by ARACNe is the Notch ligand DLL3 (Figure 3B). Active Notch
signaling is required to maintain neural cells in a multipotent,Developroliferative state and to inhibit differentiation (Hitoshi et al.,
2002; Mizutani et al., 2007; Nagao et al., 2007; Yoon and Gaiano,
2005). Therefore, we asked whether (1) DLL3 could be validated
as a direct N-Myc target gene; (2) N-Myc activates Notch
signaling; (3) DLL3 is overexpressed in Huwe1 knockout brain,
and (4) Notch signaling is activated in Huwe1 knockout brain.
The regulatory DNA region adjacent to the DLL3 gene contained
N-Myc-binding sites (E-boxes), and chromatin immunoprecipi-
tation from N-myc-amplified neuroblastoma cells demonstrated
that endogenous N-Myc is physically associated with the DLL3
promoter but not irrelevant genomic DNA sequences (Figure 4A).
Furthermore, ectopic expression of N-Myc induced the expres-
sion of DLL3 (Figure 4B) and Notch1 activation, as measured by
western blot analysis for the cleaved and activated intracellular
form of Notch1 (Notch1-IC, Figure 4C). When similar amounts
of N-Myc and c-Myc were expressed in the same cells, N-Myc,
but not c-Myc, induced the expression of DLL3 mRNA and DLL3
protein (Figures S9A and S9C). However, c-Myc induced effi-
ciently the expression of two classical Myc-target genes (ODC
and cdc25A), indicating that the inability of c-Myc to induce
DLL3 was not consequent to a generally lower transcriptional
activity by c-Myc (Figure S9A). Accordingly, N-Myc, but not
c-Myc, induced cleaved Notch1 (Figure S9B). The ability of
N-Myc, but not c-Myc, to induce DLL3 is consistent with the
presence of DLL3 in the regulon of N-Myc, but not c-Myc (Fig-
ures 3B and S8A and Tables S2 and S3). To provide further vali-
dation for the N-Myc-DLL3 axis, we asked whether expression of
N-myc and DLL3 were concurrently regulated in neural cellspmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevier Inc. 215
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growing under conditions characterized by rapid loss of stem-
ness. GBM cultures grown in serum-free Neurobasal medium
containing EGF and basic FGF (NBE) are similar to normal neural
stem cells whereas switching these cells to serum-containing
culture conditions leads to rapid loss of their stemness (Lee
et al., 2006). By using an entirely independent brain tumor data
set, a recent report compared the gene expression profile of
NBE-growing brain tumor stem cells with that from the same
cells growing in serum (Lee et al., 2006). Gene expression profile
data confirmed that N-myc and DLL3 are strongly coregulated in
this alternative data set. Additionally, the two genes were shown
to be abundantly expressed in NBE-growing brain tumor stem
cells but significantly and concurrently depleted in the serum-
growing counterparts (Figure 4D).
Next, we asked whether the elevated levels of N-Myc detected
in theHuwe1 null brain increasedDLL3 expression and activated
Notch signaling. Quantitative RT-PCR expression analysis for
the Notch ligands DLL1, DLL3, DLL4, Jagged-1, and Jagged-2
and the Notch1 gene revealed that DLL3 mRNA was the only
component of the Notch pathway elevated in Huwe1 null brain
at every developmental stage (Figures 4E and S9D). Further-
more, immunostaining of Huwe1 knockout and wild-type brains
for Notch1-IC revealed a marked increase in the absence of
Huwe1 at E15.5 (Figure 4F, upper panels) and E18.5 (Figure 4F,
lower panels). Notably, the Notch1-IC-positive domain overlap-
ped with the region showing the highest expression of the
N-Myc protein. Taken together, these findings suggest that an
N-Myc-DLL3 cascade may be a key functional target of Huwe1
during neural development.
N-Myc and DLL3 Are Responsible for the Defects
in the Huwe1 Null Brain
To explore the functional significance of the activation of the
N-Myc-DLL3 axis for the abnormalities of the Huwe1 knockout
cortex, we analyzed the consequences of silencing N-myc or
DLL3 in Huwe1 null brains. Electroporation of a Cre-GFP-
expressing plasmid in the cortical germinal layers of Huwe1Flox
embryos produced efficient recombination of the floxed allele
(Figure S10). We analyzed BrdU incorporation and performed
immunostaining for the neuronal differentiation marker TuJ1
and the DLL3 protein in sections obtained from organotypic slice
cultures derived from electroporated E14.5 Huwe1Flox brains
(Hand et al., 2005; Nguyen et al., 2006). Compared to GFP-elec-
troporated cortices, electroporation of Cre-GFP triggered the
same abnormalities detected in Huwe1F/YNes brains (increased
proliferation, impaired neuronal differentiation, and overexpres-
sion of DLL3, Figures 5A–5C). Expression of Cre-GFP in the
presence of specific siRNA oligonucleotides targeting N-myc
or DLL3, but not control siRNAs, rescued the hyperproliferation
and the differentiation defects caused by Huwe1 inactivation
(Figures 5A and 5B). Interestingly, the expression of DLL3 was
reversed in Huwe1 null cells electroporated with N-myc siRNA
oligonucleotides, indicating that loss of Huwe1 triggers ele-
vation of DLL3 through N-Myc (Figure 5C). Thus, the defects
generated by inactivation of Huwe1 require an active N-Myc-
DLL3 pathway.
To test whether ectopic expression of Huwe1 in the devel-
oping normal brain produces phenotypic and molecular effects216 Developmental Cell 17, 210–221, August 18, 2009 ª2009 Elseviethat complement those elicited by loss of Huwe1, we electropo-
rated embryo cortices with V5-tagged Huwe1 wild-type plas-
mids expressing the 500 kD full-length Huwe1 protein (V5-
Huwe1) or the catalytically inactive C4341A point mutant
(V5-Huwe1-CA). Expression of V5-Huwe1 wild-type, but not
V5-Huwe1-CA mutant, caused dramatic inhibition of cell cycle
progression and significantly reduced expression of DLL3
(Figures 6A and 6B). Taken together, these data suggest that
Huwe1 controls the timing of cell cycle withdrawal and initiation
of differentiation in the developing brain by eliminating the
N-Myc-DLL3 cascade from cortical progenitors.
The Huwe1-N-Myc Pathway Is Targeted by Genetic
and Epigenetic Alterations in Malignant Brain Tumors
It has been proposed that human brain tumors are initiated and
maintained by alterations in pathways that regulate self-renewal
and differentiation of neural stem cells (Rich and Eyler, 2008;
Stiles and Rowitch, 2008; Sutter et al., 2007). Given the impor-
tance of the Huwe1-N-Myc pathway in the biology of neural
stem cells and neurogenesis in vivo, we asked whether the
genes encoding N-myc and Huwe1 are targeted by alterations
in human brain tumors. GBM is a CNS tumor for which the
most likely cells of origin are neural stem cells. TCGA provides
data on the DNA copy number of primary GBM samples
(TCGARN, 2008). We interrogated the high-density Affymetrix
6.0 platform of SNPs arrays in the Atlas tumor collection for the
possible occurrence of genetic alterations in the N-myc and
Huwe1 loci by using the Partek Genomics Suite 6.08. Eight of
one hundred and twenty-nine (or six point two percent) tumors
carry amplification of the N-myc gene. Remarkably, we discov-
ered that two of the eight N-myc-amplified tumors (25%), but
none of the tumors lacking N-myc gene amplification, contain
focal deletions of the Huwe1 gene (FET p = 0.0034, Figure 7A).
Detailed mapping of the breakpoints revealed that both deletions
remove a minimal region including coding exons 2–20 of Huwe1
but do not affect the neighboring genetic loci (80 marker probes
are deleted in tumor #178 and 31 marker probes are deleted in
tumor #289, Figure 7B). Interestingly, Huwe1 is located on the
X chromosome (Xp11.22) and both of the two patients whose
tumors contain deletion of Huwe1 are males (XY). Therefore, the
two tumors are converted to aHuwe1 null state in a manner func-
tionally analogous to that of other tumor suppressor genes that
undergo complete loss of function in glioma (e.g., Ink4a, PTEN)
(TCGARN, 2008). Next, we asked whether loss ofHuwe1 expres-
sion is also associated with brain tumorigenesis. To this end, we
used the ONCOMINE database (www.oncomine.com), which
contains gene expression data compiled from the microarray
analysis of 23 nontumor human brain samples compared to 77
GBM samples. Interestingly, the GBM samples showed a highly
significant (p = 9.3x1010) downregulation of Huwe1 mRNA in
comparison to the corresponding brain tissues (Figure 7C).
Thus, malignant brain tumors inactivate theHuwe1 gene through
both genetic and epigenetic alterations.
DISCUSSION
Restriction of self-renewal and proliferation of neural stem cells
are coupled to neurogenesis to coordinate cortical architecture
during development. In this study, we have conditionally deletedr Inc.
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(A) Ex vivo electroporation of MSCV-GFP or MSCV-GFP-Cre plasmid together with control,N-myc, orDll3siRNA into E14.5 mouse cortices followed by organotypic
slice culture for 2 days. Cortical sections were stained for GFP (green) and BrdU (red). Arrowheads indicate GFP+/BrdU+ cells; arrows indicate GFP+/BrdU cells.
(B) Cortical slices were stained with the neuronal marker bIII-tubulin (red) and GFP (green). Arrowheads indicate GFP+/bIII-tubulin+ cells; arrows indicate GFP+/bIII-
tubulin cells.
(C) Immunofluorescence with GFP (green) and DLL3 (red) antibodies. Arrowheads indicate GFP+/DLL3+ cells. Double positive cells were scored and quantitative
results are shown as mean ± SD from at least three electroporated embryos per group from a minimum of two experiments. **p < 0.01, Student’s t test.the Huwe1 gene in the mouse brain and demonstrated that this
enzyme is essential for the transition from self-renewing and
proliferating neural stem/progenitor cells to differentiated neu-
rons. Consequently, loss of Huwe1 severely perturbs neurogen-
esis and leads to disorganization of the laminar structure of the
cortex. We have identified the ‘‘N-Myc-DLL3’’ pathway as medi-
ator of the abnormalities detected in Huwe1 null brain. The iden-
tification of this pathway is the missing link between two crucial
transcriptional regulators that provide essential signals for neuralDevelostem cell activity and inhibition of neuronal differentiation. Inter-
estingly, a recent study reported loss of Notch activation in the
mouse cortex by neural-specific mutation of another E3 ubiquitin
ligase, Mind Bomb 1 (Yoon et al., 2008). Together, we suggest
that neural development requires a fine balance of ubiquitin
ligases with positive (Mind Bomb 1) and negative (Huwe1) sig-
naling ability converging on the Notch pathway. Our work also
identifies focal intragenic deletions of the Huwe1 gene in GBM,
a human brain tumor sustained by deregulated neural-stempmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevier Inc. 217
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ligase that restrains proliferation, initiates neurogenesis, and
organizes the laminar patterning of the cortex are selected
during oncogenic transformation in the human brain.
Huwe1 Restrains Proliferation and Initiates
Neurogenesis by Suppressing an N-Myc-DLL3
Cascade in the Developing Brain
The expansion of the neural stem cell compartment elicited by
loss of Huwe1 becomes progressively more evident as neural
development proceeds and Huwe1/ neural stem/progenitor
cells fail to exit cell cycle and commence neuronal differentiation.
The deregulated proliferative activity conferred by loss of Huwe1
together with abnormal cell morphology and loss of ‘‘crowd
control’’ ultimately lead to severe perturbation of neuronal differ-
entiation and disorganization of brain architecture (Dehay and
Kennedy, 2007). During relatively early stages of neurogenesis
(before E14.5), cell cycle timing is not affected by mutation of
Huwe1. However, loss of Huwe1 severely impairs the length-
ening of the cell cycle that accompanies the progressive shift
from proliferation to differentiation during late neurogenesis.
The phenotype of the Huwe1 mutant brain in the mouse is
complementary to that caused by inactivation of transcription
factors that expand the neural stem cell compartment and inhibit
neurogenesis (N-Myc and Notch) (Hitoshi et al., 2002; Knoepfler
et al., 2002; Mizutani et al., 2007). We found that the N-Myc
protein markedly accumulated in the Huwe1 null brain and that
this effect preceded the phenotypic defects. To unravel the iden-
tity of the downstream signaling events triggered by aberrant
N-Myc in Huwe1 null brain, we designed a computational
approach to dissect and interrogate the activity of transcription
factors following modulation of candidate regulators in a specific
cellular context. From this approach, the Notch ligand DLL3
emerged as one of the strongest inferred N-Myc targets in the
brain, and we have confirmed that, during neural development,
Figure 6. Ectopic Expression of Huwe1 Inhibits
Proliferation and Impairs Expression of DLL3
(A) Ex vivo electroporation of pcDNA3.1/V5-His/LacZ,
pcDNA3.1/V5-Huwe1-WT, and pcDNA3.1/V5-Huwe1-CA
plasmid into E14.5 mouse cortices followed by organo-
typic slice culture for 2 days. Cortical sections were
double-stained with V5 (green) and BrdU (red). Arrow-
heads indicate V5+/BrdU+ cells; arrows indicate
V5+/BrdU cells.
(B) Cortical sections were stained with V5 (green) and
DLL3 (red). Arrowheads indicate V5+/DLL3+ cells. Double
positive cells were scored and quantitative results are
shown as mean ± SD from at least three electroporated
embryos per group from a minimum of two experiments.
**p < 0.01.
Huwe1 negatively regulates expression of DLL3
in an N-Myc-dependent fashion. Based on this
information, we have experimentally validated
DLL3 as a direct transcriptional target of
N-Myc and, most importantly, we discovered
that the hyperproliferation and neuronal differ-
entiation defects resulting from knocking out
Huwe1 in the cortex are fully reversed by
silencing the expression of DLL3 in vivo. Thus, the N-Myc-
DLL3 cascade is restrained by Huwe1 to set the timing of cell
cycle withdrawal and neuronal differentiation in the developing
brain. Although our results are consistent with DLL3 activating
Notch1 in the neural stem cell compartment at midgestation, in
other systems DLL3 might also behave as inhibitor of Notch1,
possibly through competition with other Notch ligands (Geffers
et al., 2007; Ladi et al., 2005).
Huwe1 as Tumor Suppressor Gene in GBM
Activation of stem cell activity and deregulation of N-Myc (and
Notch) have been linked to tumorigenesis in the brain (Stiles
and Rowitch, 2008; Sutter et al., 2007). High-density gene
copy number analysis discovered that at least two tumors
(both of which originated in male patients) had highly focal dele-
tions that were entirely contained within the coding region of the
Huwe1 gene. The reduced expression of Huwe1 in GBM sug-
gests that epigenetic alterations may be more frequently
involved. Thus,Huwe1 resembles the X-linked tumor suppressor
WTX gene, for which inactivation of the single allele in tumor-
bearing male patients is sufficient to create a complete loss-of-
function status in tumor cells (Rivera et al., 2007). The Huwe1
mutations display an additional feature in that they coexist with
N-myc gene amplification in GBM. Although the finalistic concur-
rence of N-myc and Huwe1 alterations in the same tumors may
seem counterintuitive, cooperation between two independent
genetic events is consistent with the mechanisms leading to
activation of c-Myc in Burkitt’s and other lymphomas, in which
transcriptional deregulation of the c-myc gene requires translo-
cation to the immunoglobulin loci and is associated with escape
from ubiquitin-mediated degradation by the c-Myc protein
through independent mutation of regulatory phosphorylation
sites (Bahram et al., 2000; Bhatia et al., 1993). Thus, the short
half-life of the N-Myc protein in neural cells requires that the
increasingly synthesized protein in brain tumors be stabilized218 Developmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevier Inc.
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(A) Eight of one hundred twenty-nine GBM contain amplification of the N-myc gene, and two of them (#178 and #289) have focal deletions of Huwe1.
(B) The two Huwe1 deletions occur in male (XY) patients and define a focal minimal common region of deletion of 65 kb, which is entirely contained within the
Huwe1 gene. The blue, dashed lines define the limits of the deletions for each tumor.
(C) The expression of Huwe1 is significantly downregulated in 77 samples from human GBM (class 2, red) compared with 23 samples from nontumor human brain
(class 1, blue); p = 9.3x1010. Boxes, interquartile range of expression values. The whiskers extend to the 5th and 95th percentile of expression values.by independent genetic loss of the gene encoding for the ubiqui-
tin ligase Huwe1. We predict that neural stem cells carrying
concurrent deletion of Huwe1 and transcriptional activation of
the N-myc oncogene gain the most powerful myc-associated
activities necessary for oncogenic transformation.
EXPERIMENTAL PROCEDURES
Generation of Huwe1Flox Nes Mice
To generate Huwe1F/YNes animals, heterozygous or homozygous floxed
Huwe1 females (Huwe1Flox/X or Huwe1Flox/Flox) were bred onto Nestin-Cre
heterozygous males. Huwe1 mutants were genotyped by PCR of genomic
DNA prepared from tail biopsies using primers described previously (Zhao
et al., 2008). All animal experiments were approved by and performed in accor-
dance with the guidelines of the International Agency for Research on Cancer’s
Animal Care and Use Committee.
Tissue Preparation for Paraffin-Embedded Sections
and Immunostaining
Short pulse BrdU (Sigma-Aldrich) labeling was carried out by injecting preg-
nant mice with BrdU intraperitoneally (50 mg/g body weight) 1 hr prior to sacri-
fice. For birthdating experiments, timed-pregnant mice (at E12.5 and E15.5)
were injected with BrdU intraperitoneally at 40 mg/g body weight. PFA-
perfused embryos (E13.5 and E15.5) or dissected brains (E18.5 and P0)
were fixed for 24 hr in 10% formalin. Five-micron paraffin sections were depar-
affinized, rehydrated, treated for antigen retrieval, and incubated in 10% serum
blocking solution prior to the incubation with primary antibodies at room tem-
perature (RT) for 1 hr or at 4C for 18 hr. For BrdU staining, sections were
treated with 3N HCl for 50 min at RT followed by two rinses of 0.1 M boricDeveloacid (pH 8.0) for 5 min at RT prior to blocking. Fluorescent detection was
performed with Cy3 or FITC-labeled secondary antibodies (Jackson Immunor-
esearch Laboratories), whereas biotin-conjugated secondary antibodies
(Vector Laboratories) were employed for Vectastain Elite ABC development.
Tyramide amplification system (Perkin Elmer) was used for Notch-IC, N-Myc,
and cyclin D1 immunodetection according to the manufacturer’s instructions.
The primary antibodies used were as follows: anti-cleaved Notch1 (Val1744,
Cell Signaling Technology); anti-BrdU (Roche); anti-Ki67 (Novocastra); anti-
Ctip2 (Abcam); anti-MAP2 (Sigma); anti-GAP43, anti-cyclin D1, and anti-
HuC/D (Invitrogen); anti-N-Myc (Calbiochem); anti-HUWE1 HECT-domain
(Lifespan Biosciences); anti-HUWE1-Lasu1 (Bethyl Laboratories); anti-p27
(Thermo Scientific); anti-Tbr1, anti-Tbr2, anti-Reelin, and anti-Pax6 (Millipore);
and anti-Cux1 (Santa Cruz).
Ex Vivo Electroporation and Immunostaining on Cryosections
Ex vivo electroporation was performed as described previously with minor
modifications (Zhao et al., 2008). Huwe1 floxed embryos were recovered at
E14.5. Endotoxin-free GFP plasmid (1 mg/ml, MSCV-GFP or MSCV-Cre-GFP)
mixed with siRNA (10 mM, N-myc, DLL3, and Control Smart Pool, Dharmacon)
were injected into lateral ventricles using a Femtojet microinjector (Eppendorf).
In Huwe1 overexpression experiments, pcDNA3.1/V5-His/LacZ, pcDNA3.1/
V5-Huwe1-WT or pcDNA3.1/V5-Huwe1-CA plasmids (2 mg/ml) were used for
electroporation. Electroporated cerebral hemispheres were dissected and
sectioned coronally into 300 mm thick slices using a vibratome (VT1000S,
Leica). The slices were cultured for 2 days in neurobasal medium containing
1% N2, 1% B27, 2 mM L-glutamine, penicillin-streptomycin, and fungizone.
Medium was changed every day. Slices were labeled with 10 mM BrdU for
2 hr followed by fixation in ice-cold 4% PFA at 4C for 20 hr. Fixed slices
were incubated for 24 hr in PBS containing 15% sucrose followed by 24 hr
incubation in PBS with 30% sucrose and embedded in optimal cuttingpmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevier Inc. 219
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three brains per group from two independent experiments were used. The anti-
bodies used for double staining on cryosections were as follows: Brdu (Roche),
anti-Brdu (Abcam), anti-V5 (Invitrogen), anti-bIII-tubulin (Promega), anti-DLL3
(Santa Cruz), and anti-GFP (Invitrogen). Confocal images acquired with a Zeiss
Axioscop2 FS MOT microscope were used to score double positive.
Statistical Analysis
Each experiment was performed with samples from at least three animals from
two independent litters. In histograms, values represent the mean values; error
bars are standard deviations. Statistical significance was determined by t test
(with Welch’s Correction) using GraphPad Prism 4.0 software (GraphPad Inc.,
San Diego, CA).
ARACNe
ARACNe employs an information theoretic approach to infer transcriptional
interactions by considering statistical dependencies between the gene expres-
sion profiles (Basso et al., 2005). The algorithm first distinguishes candidate
interactions between a transcription factor and its potential target by com-
puting pairwise mutual information (MI) taking advantage of a computationally
efficient Gaussian Kernel estimator. The algorithm then eliminates the vast
majority of interactions that are likely mediated by another transcription factor
using the Data Processing Inequality (DPI) theorem. The procedure is repeated
for 100 times to generate a set of bootstrap networks with pseudo data sets
randomly sampled (with replacement) from the original data set. Finally,
a consensus network is constructed by retaining interactions supported across
a significant number of the bootstrap networks. In contrast to coexpression
networks, ARACNe explicitly discriminates between direct and indirect tran-
scriptional interactions, an essential feature in reducing false positives among
the inferred targets of a transcription factor. In transcriptional networks it has
been shown that a small percent of genes accounts for most of the interaction;
the transcription factors with the largest number of regulated targets in the
network are called hubs (Barabasi and Oltvai, 2004; Zhu et al., 2007).
GSEA2
Microarray samples were first partitioned into two 35% subsets where Huwe1
is relatively most and least expressed. GSEA2 was used to assess whether
transcriptional targets of a transcription factor are statistically enriched in
genes differentially expressed between the two subsets. The algorithm con-
siders differential expressions of a transcription factor’s positive and negative
targets as the reflection of changes in the transcription factor’s activity.
Supposing that activity of a transcription factor is negatively associated with
the abundance of Huwe1 (e.g., Huwe1 ubiquitinates and degrades a transcrip-
tion factor), one would expect the transcription-factor-activated targets to be
enriched in genes that are downregulated, whereas the transcription-factor-
repressed targets would be enriched in genes that are upregulated when
Huwe1 is highly expressed. Statistical significance of the enrichment is then
determined by comparing the observed enrichment score to the null distribu-
tion computed through random permutation of the transcriptional target sets.
Details of the algorithm have been previously described in Lim et al. (2009).
Promoter Analysis and Chromatin Immunoprecipitation
Promoter analysis was performed using MatInspector software (www.
genomatix.de). A sequence of 2 kb upstream and 2 kb downstream from the
transcription start site was analyzed for the presence of putative E-box
sequences. Primers used to amplify sequences surrounding the predicted
binding sites were designed using Primer3 software (http://frodo.wi.mit.edu/
cgi-bin/primer3/primer3_www.cgi).
Chromatin immunoprecipitation was performed as described in Frank et al.
(2001). IMR32 cells were crosslinked with 1% formaldehyde for 10 min and
stopped with 0.125 M glycine for 5 min. Cells were washed in PBS and har-
vested in sodium dodecyl sulfate buffer. After centrifugation, cells were resus-
pended in ice-cold immunoprecipitation buffer and sonicated to obtain
fragments of 500–1000 pb. Lysates were centrifuged at full speed and the
supernatant was precleared with Protein A/G beads (Santa Cruz Biotech-
nology) and incubated at 4C overnight with 1 mg of polyclonal antibody
specific for N-Myc (C-19, Santa Cruz Biotechnology) or 1 mg of normal rabbit
immunoglobulins (Santa Cruz Biotechnology). The immunocomplexes were220 Developmental Cell 17, 210–221, August 18, 2009 ª2009 Elsevierecovered by incubating the lysates with protein A/G for 1 hr at 4C. After
extensive washing the immunocomplexes were eluted and reverse cross-
linked, and DNA was recovered by phenol-chloroform extraction and ethanol
precipitation. DNA was eluted in 200 ml of water and 1 ml was analyzed by PCR
with Platinum Taq (Invitrogen). The sequence of the primers used is listed as
follows: DLL3: Forward, AGCGTCACACAATCACGAAG; Reverse, TGGTATGA
ACCAGAGCTACCG; OLR: Forward, ACTGCACCTGGCCAACTTTT; Reverse,
TGCAAAGAAAAGAATACACAAAGGA.
N-myc and Huwe1 Gene Copy Number Analysis
Copy number analysis on the TCGA GBM samples was done using Partek
Genomics Suite 6.08 (http://www.partek.com/). Both paired and unpaired
analysis was done to get the raw copy numbers since some tumor samples
did not have corresponding normal samples. To identify regions of amplifica-
tion and deletion, the genomic segmentation algorithm of Partek was imple-
mented with the following parameters: minimum of ten genomic markers at
a p value of 0.001 and a signal-to-noise ratio of 0.3. A p value of 0.01 was
used to filter for regions of interest from the segmentation results.
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